HB-1901

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug NameHB-1901
Drug Alias NameHB-1901HB1901
ClassificationBiologics
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCSPC Megalith Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCSPC Megalith Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A